Оценка Влияния Ингибитора Натрий-глюкозного Котранспортера 2 Типа В Сочетании С Инсулином На Метаболические Параметры И Морфофункциональные Изменения Почек Крыс С Экспериментальным Сахарным Диабетом
Year: 2017
Type: article
Abstract: Sodium-glucose co-transporter type 2 inhibitors belong to modern class of oral hypoglycemic drugs, exerting its effect through the reduction of renal glucose reabsorption. In addition to the hypoglycemic effect, various pleiotropic effects are described for this group of drugs. This article describes the effects of four-week treatment of diabetic rats by sodium-glucose co-transporter type 2 inhibitor dapagliflozin on various metabolic parameters and renal morphofunctional changes. We obtained that the addition of dapagliflozin to insulin-treated rats with streptozotocin-induced diabetes reduced the severity of glomerulosclerosis, and albuminuria.
Source: Juvenis scientia
Language: Russian
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3048076620
